A Case of Drug-Induced Hepatitis due to Lenalidomide
Lenalidomide is a recent thalidomide analog used for the treatment of refractory multiple myeloma. The main toxicity of this drug consists in severe neutropenia and thrombocytopenia. Lenalidomide-associated liver injury is rare, manifesting itself as elevated liver enzymes and hyperbilirubinemia rev...
Main Authors: | M.-C. Zanella, L. Rubbia-Brandt, E. Giostra, Y. Chalandon, A. Hadengue, L. Spahr |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2011-04-01
|
Series: | Case Reports in Gastroenterology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/326935 |
Similar Items
-
Discontinuation of immunosuppression in patients with immune‐mediated drug‐induced liver injury or idiopathic autoimmune hepatitis: A case–control study
by: Jeremy Hassoun, et al.
Published: (2023-02-01) -
How to Manage Patients with Lenalidomide-Refractory Multiple Myeloma
by: Felipe de Arriba de la Fuente, et al.
Published: (2022-12-01) -
A noninterventional observational registry of patients with multiple myeloma treated with lenalidomide in Taiwan
by: Shang-Yi Huang, et al.
Published: (2017-09-01) -
A case of severe hypothyroidism due to lenalidomide
by: Rachel A. Blair, et al.
Published: (2019-09-01) -
Database study of lenalidomide (Revlimid) in Germany: monitoring off-label use [Monitoring des Off-Label-Use von Lenalidomid (Revlimid) in Deutschland]
by: Dörks, Michael, et al.
Published: (2013-07-01)